Covid-19 coming back in Bahrain

Bahrain records 1,000 Covid-19 cases in two months as pandemic continues, highlighting the need for vigilance. Monkeypox outbreak in the UK also contributes to rising cases. Vaccination efforts have helped combat the epidemic, with multiple approved vaccines. Insights from a UK database show efficacy of anti-pandemic vaccinations in reducing hospitalizations and fatalities.

Medriva Newsroom
New Update



Bahrain has recorded 1,000 Covid-19 cases in two months.


In less than two months, Bahrain has hosted 1,000 Covid-19 activities. Yesterday, the Ministry of Health announced 1,008 instances, underlining the need for vigilance.

A well-known doctor told The Daily Tribune that the pandemic is far from over.

Covid-19 cases are rising as monkeypox spreads in the UK.


Vaccination and disease prevention helped the kingdom beat the epidemic.

The Kingdom has also authorized Johnson and Johnson Ad26.COV2.S, Bharat Biotech Covaxin, Covishield AstraZeneca, Sinopharm Covilo, and ValnevaVLA2001.

Bahrain approved, received, and administered Valneva's Covid-19 vaccination. Saudi Arabian vaccine recipients commonly experienced covid infection, hospitalization, and fatality.

Dr. Sid Mukherjee evaluated four anti-pandemic vaccinations in UK's Covid-19 database.

Because all four vaccines reduced COVID-19-related ICU admissions, hospitalizations, and fatalities, SARS CoV-2 infection was more prevalent among Sinopharm vaccine recipients than in other vaccine recipients.

Chat with Dr. Medriva !